Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Glucagon-like peptide-1, or GLP-1, has been studied by scientists for over 30 years, with the first GLP-1 receptor agonist approved for diabetes in 2005. Today, PlexusDx brings this proven science to personalized weight loss therapy through compounded semaglutide and tirzepatide formulations tailored to your genetic profile.
GLP-1 Discovery and Early Research Timeline
Scientists first identified GLP-1 as a natural hormone in the human gut during the early 1990s. Researchers noticed that this peptide influenced blood sugar control and appetite regulation in ways that could benefit people with type 2 diabetes. The initial breakthrough came when labs demonstrated that GLP-1 mimicked the body's own signaling to reduce hunger and improve insulin sensitivity. This foundation laid the groundwork for decades of pharmaceutical development.
The first synthetic GLP-1 receptor agonist, exenatide, received FDA approval in 2005 for type 2 diabetes management. Clinical trials showed that patients taking GLP-1 drugs experienced significant improvements in blood glucose levels and modest weight loss as a secondary benefit. This approval marked a turning point: GLP-1 therapy moved from experimental research into mainstream medical practice. Endocrinologists began prescribing these medications to millions of patients worldwide seeking better metabolic control.
How GLP-1 Works Inside Your Body
GLP-1 is an incretin hormone that your intestines naturally release when you eat. It signals your pancreas to produce insulin only when blood sugar rises, helping your body maintain stable glucose levels throughout the day. The hormone also slows stomach emptying, which extends feelings of fullness and reduces overall calorie intake. Additionally, GLP-1 receptors in your brain's appetite centers trigger satiety signals that make you feel satisfied with smaller meals.
GLP-1 receptor agonists like semaglutide and tirzepatide act as keys that unlock these same receptor sites your body already uses. By mimicking natural GLP-1, these medications amplify your existing metabolic pathways without introducing entirely foreign compounds. This mechanism explains why GLP-1 therapy works across different body types and why PlexusDx emphasizes genetic testing to identify which patients respond most favorably to specific GLP-1 formulations.
The Shift from Diabetes to Weight Loss Medicine
In the mid-2010s, researchers conducting diabetes trials noticed an unexpected pattern: patients were losing significant amounts of weight, often 10–15% of their body mass. These observations prompted new clinical studies designed specifically to measure GLP-1's effect on weight loss rather than glucose control. The STEP trials (2021–2023) demonstrated that semaglutide produced weight loss comparable to or exceeding older weight loss surgeries, without requiring invasive procedures. This evidence shifted GLP-1 from a diabetes drug with side benefits into a legitimate first-line obesity treatment.
Media coverage and celebrity adoption accelerated patient demand beyond what even pharmaceutical companies anticipated. Shortages occurred as demand outpaced supply from traditional pharmaceutical manufacturers. This shortage created an opportunity for licensed compounding pharmacies to provide access to semaglutide and tirzepatide for more patients. PlexusDx partners with 503A compounding pharmacies to deliver these proven medications at transparent, flat monthly prices—starting at $149/mo for compounded semaglutide injection—making GLP-1 therapy accessible regardless of insurance status.
Personalized GLP-1 Therapy and Genetic Insights
While GLP-1 has been around for 30 years, personalization is new. Not everyone responds equally to semaglutide or tirzepatide, and dosing requirements vary based on individual metabolism and genetics. PlexusDx introduced the Precision Peptide Genetic Test to identify how your unique DNA affects GLP-1 pathways. The test maps 14 metabolic pathways and analyzes key variants like GIPR rs1800437 and GLP1R rs6923761, which directly influence how your body processes and responds to GLP-1 medications.
Genetic testing allows PlexusDx to recommend whether you benefit most from semaglutide injection, oral semaglutide, tirzepatide, or the dual-compound GLP-Squared protocol. Your dose may need to go up as your treatment progresses—but your price won't. All PlexusDx formulations are flat-rate monthly fees, meaning you'll pay the same whether you're at maintenance dose or higher therapeutic levels. This transparency removes a major barrier to accessing the longest-studied weight loss therapy available today.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How long has GLP-1 actually been around as a treatment?
GLP-1 was discovered as a natural hormone in the early 1990s, and the first FDA-approved GLP-1 medication (exenatide) launched in 2005 for diabetes. That's nearly two decades of clinical use before weight loss applications gained attention. PlexusDx offers compounded versions of the most researched GLP-1 compounds available, backed by over 15 years of diabetes safety data plus newer STEP trial evidence for weight loss.
Is GLP-1 safe if it's been around so long?
Yes. The 2005–2024 safety record for GLP-1 receptor agonists is extensive, covering millions of patients globally. Common side effects include nausea and constipation, which typically diminish over time. Serious side effects are rare and are monitored during treatment. PlexusDx patients receive ongoing support and can adjust their approach with medical guidance, ensuring safety remains the priority throughout therapy.
Why should I choose PlexusDx compounded semaglutide over brand-name versions?
PlexusDx compounded semaglutide injection starts at $149/mo and is formulated by licensed 503A compounding pharmacies to the same pharmaceutical standards as brand products. You save significantly compared to brand pricing, require no insurance, and your dose adjustments don't trigger price increases. PlexusDx also integrates genetic testing to personalize your specific compound selection—semaglutide, tirzepatide, or the GLP-Squared dual formulation.
What does the Precision Peptide Genetic Test reveal?
The test analyzes your DNA for variants in 49 peptide-related genes across 14 metabolic pathways, including GLP1R rs6923761 and GIPR rs1800437, which directly affect how your body responds to GLP-1 medications. This genetic roadmap helps PlexusDx clinicians recommend whether you'll respond best to semaglutide, tirzepatide, or a dual-compound approach, maximizing your treatment success from day one.
Does PlexusDx work with insurance or HSA/FSA accounts?
PlexusDx serves all 50 states without requiring insurance, but all medications and the Precision Peptide Genetic Test ($99 add-on after first month) are HSA/FSA eligible. You'll receive an invoice you can submit to your HSA/FSA administrator for reimbursement, making personalized GLP-1 therapy even more affordable.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Low Dose Semaglutide Work for Sustainable Weight Management?
What Can I Take with Semaglutide to Lose Weight?